Max-Planck-Gesellschaft Zur Foerderung der Wissen-Schaften E.V. v. Whitehead Institute for Biomedical Research

MEMORANDUM AND ORDER

SARIS, District Judge.

Plaintiffs Max-Planck-Gesellschaft Zur Forderung der Wissenschaften E.V. (“Max *319Planck”) and Alnylam Pharmaceuticals, Inc. (“Alnylam”) have sued defendants Whitehead Institute for Biomedical Research (“Whitehead”), Massachusetts Institute of Technology (“MIT”), and the Board of Trustees of the University of Massachusetts (“UMass”) over the intellectual property rights to certain inventions in the field of “RNA interference.” The parties have filed cross-motions for partial summary judgment.

The plaintiffs request that the Court find as a matter of law…